When used to treat Actinic Keratoses, PDT is often covered by insurance since it is an FDA-approved medical treatment for precancerous lesions
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
Experience & Education Tennr ***** ******* ******* ******** ********** ***** ******* ******* ****** ***** **** ****** ***** ******* ******* ****** ******** ******** ********* ******* undefined ******** ******* - View William H.s full experience See their title, tenure and more
The best peptide vendors guide covers what to look for in a supplier, and the peptide testing labs guide explains how to verify peptide purity and identity
Table of Contents What Is BPC-157 and How Does It Work
This yields a total weekly dose of 1,500 IU
